Biotech Prometheus Biosciences to Host a Virtual R&D Day for Analysts and Investors on July 26, 2022 July 22, 2022
Biotech Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 22, 2022
Biotech Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis July 22, 2022
Biotech Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results July 22, 2022
Biotech BridgeBio Pharma Announces Founding Affiliation with Bakar Labs, Incubator at UC Berkeley’s Bakar BioEnginuity Hub July 22, 2022
Biotech Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis July 22, 2022